Victoria University of Wellington and University of Auckland, in New Zealand (NZ) have been named as co-hosts of a ...
In a boost to regenerative therapies for damaged hearts and eyes, Duke-NUS in Singapore has licensed two laminin-related...
Epilepsy affects over 150,000 Australians, and 50 million globally, with one-third struggling to control their condition...
A newly discovered “energy switch” in the immune cells of the brain may lead to the development of drugs for...
More efficient and longer lasting glucose-responsive insulin that eliminates the need for people with type 1 diabetes to...
The Chinese University of Hong Kong (CUHK)’s Faculty of Medicine (CU Medicine) conducted a randomised, placebo-con...
A molecule discovered by Distinguished Professor Dame Margaret Brimble of the University of Auckland, New Zealand is the...
Around 50 Australian children are born every year with devastating mitochondrial disease, with an expected lifespan of o...
Researchers from the Antimicrobial Resistance (AMR) Interdisciplinary Research Group (IRG) at Singapore-MIT Alliance for...
Please share more details about the technology that has been transferred by Olink to NUS? What is so unique...
The Yong Loo Lin School of Medicine, National University of Singapore (NUS Medicine) has launched the NUS Medi...
Scientists in Japan have revealed a chemical compound that could be used for the treatment of various autoimmune disease...
Australian biotechnology leader CSL has announced that the European Commission has granted conditional marketing authori...
South Korean startup LISCure Biosciences Inc. has announced a multi-year strategic R&D collaboration with Celltrion ...
Singapore-headquartered biopharmaceutical company Specialised Therapeutics (ST) has announced that its portfolio therapy...
Australia's University of Sydney scientists have discovered a protein in the lung that blocks SARS-CoV-2 infection and f...
Applications of new molecules as drugs are expected to be effective in treating diseases that are difficult to cure with...
What is Anticancer Bioscience’s competitive edge and what is unique about the pipeline you are developing?&n...
